Qian-xi Ni

Dr. Qian-xi Ni


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2018 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
YZYue Zhou
Yue Zhou
XSXiaowu Sheng
Xiaowu Sheng
FDfeiyan deng
feiyan deng
HWHui Wang
Hui Wang
QLQixin Liu
Qixin Liu
XZXiao Zhou
Xiao Zhou
Lack of animal model of radiation induced muscle fibrosis, this study aimed to establish such a model by using 90 Gy single dose irradiation to mimic clinical relevance and also to explore the potential post-irradiation regenerative mechanism. SD rats were randomly divided into dose investigation groups and time gradient groups. Group1–6 were irradiated with a single dose of 65Gy, 70Gy, 75Gy, 80Gy, 85Gy and 90Gy respectively, and the degree of rectus femoris fibrosis in the irradiated area was detected at 4 weeks after irradiation. Group 7–9 were irradiated with a single dose of 90Gy, and the results were detected 1, 2, 4, and 8 weeks after irradiation. Then the general condition of rats was recorded. Masson staining was used to detect muscle fibrosis. The ultrastructure of muscles was observed by electron microscope, and the expression changes of satellite cell proliferation and differentiation related genes were detected by quantitative real-time-PCR. A single dose of 90Gy irradiation could cause muscle fibrosis in rats. As time goes on, the severity of muscle fibrosis and the expression of TGF- β1 increased. Significant swelling of mitochondria, myofilament disarrangement and dissolution, obvious endothelial cell swelling, increased vascular permeability, decrease of blood cell, deposition of fibrosis tissue around the vessel could be found compared with the control group. At around the 4th week, the expressions of Pax7, Myf5, MyoD, MyoG, Mrf4 increased. Irradiation of 90Gy can successfully establish the rat model of radiation-induced muscle fibrosis. This model demonstrated that regenerative process was initiated by the irradiation only at an early stage, which can serve a suitable model for investigating regenerative therapy for post-radiation muscle fibrosis.

11 July 2024 in Nuclear Science and Techniques
Verified
Journal Article
Closed access
PDF file
YLYuan-Qiao Li
Yuan-Qiao Li
MLMin Lin
Min Lin
LXLi-Jun Xu
Li-Jun Xu
RLRui Luo
Rui Luo
YZYu-He Zhang
Yu-He Zhang
YLYun-Tao Liu
Yun-Tao Liu

6 October 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JZJun Zhu
Jun Zhu
QZQionghui Zhou
Qionghui Zhou
LCLuqiao Chen
Luqiao Chen
ZHZhipeng He
Zhipeng He
JTJianfeng Tan
Jianfeng Tan
QNQian-xi Ni
Qian-xi Ni
Hematologic toxicity (HT) is a common and serious side effect for advanced cervical cancer patients undergoing chemoradiotherapy. Accurately predicting HT can significantly improve patient management and treatment outcomes. This study aims to develop and evaluate interpretable machine learning models that use radiomic and dosimetric features to predict HT in advanced cervical cancer patients. Retrospectively collected general clinical data, planning CT images, and dose files from 205 patients with advanced cervical cancer who underwent chemoradiotherapy, and classified them according to the severity of HT. Radiomics and dosiomics features were extracted from the same region of interest, and feature selection was performed using a random forest algorithm. Radiomics models, dosiomics models, and hybrid models were then constructed based on extreme gradient boosting trees. Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) were calculated to evaluate the classification performance of the models. Finally, SHAP values were used to perform interpretability analysis on the best model to enhance the transparency and practicality of the model. The sensitivity, specificity, and AUC values for the radiomics model were 0.42, 0.86, and 0.78, respectively, while those for the dosiomics model were 0.50, 0.90, and 0.74. In contrast, the hybrid model exhibited superior classification performance with sensitivity, specificity, and AUC values of 0.50, 0.83, and 0.83, respectively. Compared to the standalone radiomics and dosiomics models, the hybrid model demonstrated enhanced classification capability. Interpretability analysis based on SHAP values not only provided a ranking of feature importance and the distribution of feature impacts on model outputs but also elucidated the specific decision-making processes influenced by these features and the interactions between them. This enables clinicians to gain a more intuitive understanding of the model's decisions. For patients with advanced cervical cancer undergoing chemoradiotherapy, the integration of radiomics and dosiomics features can significantly enhance the classification performance of predictive models, thereby holding considerable potential for refining patient treatment strategies. Interpretability analysis based on SHAP values can aid clinicians in more readily understanding the model's decisions, thus promoting the effective implementation of the model in clinical practice.

13 October 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
XSXiangshang Sun
Xiangshang Sun
SHShixiong Huang
Shixiong Huang
XZXing Zhou
Xing Zhou
BZBorong Zhou
Borong Zhou
ZWZhiyan Wang
Zhiyan Wang
QNQian-xi Ni
Qian-xi Ni
With accumulating evidence confirming that postoperative adjuvant radiotherapy improves survival outcomes in patients with left-sided breast cancer, the long-term cardiotoxicity risks associated with radiotherapy have attracted widespread attention. The deep inspiration breath hold (DIBH) technique increases the distance between the heart and the breast target, effectively reducing radiation dose to the heart and coronary arteries. However, the resource-intensive nature of DIBH and substantial heterogeneity in therapeutic benefits among patients pose a major clinical challenge: how to accurately and efficiently identify patients suitable for DIBH. This narrative review summarizes current evidence regarding DIBH patient selection, and integrates available strategies with clinical workflows to construct a three-tiered decision-making framework encompassing feasibility assessment, indication evaluation, and clinical benefit assessment. Given the existing gaps in high-level prospective clinical evidence, three primary research directions are proposed: (1) conducting large-scale multi-center prospective cohort studies to validate the generalizability and clinical practicality of selection strategies; (2) developing an individualized normal tissue complication probability (NTCP) model integrating multi-dimensional risk factors to guide precise decision-making; and (3) implementing prospective clinical trials of artificial intelligence (AI)-assisted selection platforms to accelerate the clinical translation of intelligent selection tools. This review synthesizes current evidence on DIBH patient selection, constructs a hierarchical decision framework to provide a reference for clinical practice, and delineates directions for future research.